Stockreport

Trillium +44% after report of possible Forty Seven takeover [Seeking Alpha]

Trillium Therapeutics Inc. - Common Shares  (TRIL) 
Last trillium therapeutics inc. - common shares earnings: 5/13 07:00 am Check Earnings Report
PDF Trillium Therapeutics (NASDAQ: TRIL jumped 43.6% FTSV takeover offer Trillium is working on a medicine similar to that in Forty Seven's lead program (magrolimab), a mono [Read more]